This session covers key considerations for sites, sponsors and CROs when a sponsor delegates clinical trial agreement negotiation and execution to a CRO.

The speakers address the risks of utilizing CROs for CTA negotiations, additional steps that sites and sponsors should take to ensure they are protected when contracting with CROs and the benefits that CROs can bring to the contract process.